Peptide - Major histocompatibility complex Class I complex: From the structural and molecular basis to pharmacological principles and therapeutic applications

Current Topics in Microbiology and Immunology

Volumn 232, Issue , 1998, Pages 75-97

  Hudrisier, Denis ^a,b   Gairin, Jean Edouard ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; BINDING AFFINITY; MAJOR HISTOCOMPATIBILITY COMPLEX; PARASITOSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; T LYMPHOCYTE ACTIVATION; THERMODYNAMICS; VIRUS INFECTION;

EID: 0031966501     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-72045-1_4     Document Type: Review

References (12)

1. Aichele P, Brduschariem K, Zinkernagel RM, Hengartner H, Pircher H (1995) T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med 182:261-266
2. Ajitkumar P, Geier SS, Kesari KV, Borriello F, Nakagawa M, Bluestone JA, Saper MA, Wiley DC, Nathenson SG (1988) Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell 54:47-56
3. Alramadi BK, Jelonek MT, Boyd LF, Margulies DH, Bothwell ALM (1995) Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J Immunol 155:662-673
4. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96
5. Anjuere F, Horvath C, Cerottini JC, Luescher IF (1995) Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface. Eur J Immunol 25:1535-1540
6. Ayyoub M, Mazarguil H, Monsarrat B, van den Eynde B, Gairin JE (1997) A structurally modified, peptidase-resistant analogue of human tumor antigen MZ2-E is a potent activator of anti-melanoma cytotoxic T lymphocytes. Proceedings of the 13th European Immunology Meeting, 22-25 June, Amsterdam, p 5.10
7. Barber LD, Parham P (1994) The essence of epitopes. J Exp Med 180:1191-1194
8. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410
9. Bjorkman PJ (1990) Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Immunol 59:253-288
10. Bjorkman PJ, Saper MA, Samraoui B, Bennet WS, Strominger JL, Wiley DC (1987a) The foreign antigen binding site and T cell recognition region of class I histocompatibility antigens. Nature 329:513-518
11. Bjorkman PJ, Saper MA, Samraoui B, Bennet WS, Strominger JL, Wiley DC (1987b) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512
12. Boon T, Cerottini JC, Van den Eynde B, Vanderbruggen P, Vanpel A (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337-365